Literature DB >> 7486898

Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole.

T W Chin1, M Loeb, I W Fong.   

Abstract

Absorption of ketoconazole is impaired in patients with achlorhydria. The purpose of this study was to determine the effectiveness of a palatable acidic beverage (Coca-Cola Classic, pH 2.5) in improving the absorption of ketoconazole in the presence of drug-induced achlorhydria. A prospective, randomized, three-way crossover design with a 1-week wash-out period between each treatment was employed. Nine healthy nonsmoking, nonobese volunteers between 22 and 41 years old were studied. Each subject was randomized to receive three treatments: (A) ketoconazole 200-mg tablet with water (control), (B) omeprazole (60 mg) followed by ketoconazole (200 mg) taken with water, and (C) omeprazole (60 mg) followed by ketoconazole (200 mg) taken with 240 ml of Coca-Cola Classic. The pH values of gastric aspirates were checked after omeprazole was administered to confirm attainment of a pH of > 6. Multiple serum samples were obtained for measurements of ketoconazole concentrations by high-pressure liquid chromatography. The mean area under the ketoconazole concentration-time curve from zero to infinity for the control treatment (17.9 +/- 13.1 mg.h/liter) was significantly greater than that for treatment B (3.5 +/- 5.1 mg.h/liter; 16.6% +/- 15.0% of control). The mean peak concentration was highest for the control treatment (4.1 +/- 1.9 micrograms/ml), for which the mean peak concentration showed a significant increase over that for treatment B. The absorption of ketoconazole was reduced in the presence of omeprazole-induced achlorhydria. However, drug absorption was significantly increased, to approximately 65% of the mean for the control treatment, when the drug was taken with an acidic beverage, such as Coca-Cola.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7486898      PMCID: PMC162805          DOI: 10.1128/AAC.39.8.1671

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Sample size determination for bioequivalence assessment by means of confidence intervals.

Authors:  E Diletti; D Hauschke; V W Steinijans
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1991-01

2.  Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  G Lake-Bakaar; E Quadros; S Beidas; M Elsakr; W Tom; D E Wilson; H P Dincsoy; P Cohen; E W Straus
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

3.  Effect of food and gastric acidity on absorption of orally administered ketoconazole.

Authors:  P Lelawongs; J A Barone; J L Colaizzi; A T Hsuan; W Mechlinski; R Legendre; J Guarnieri
Journal:  Clin Pharm       Date:  1988-03

4.  Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.

Authors:  C W Howden; J A Forrest; J L Reid
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

5.  Disposition of ketoconazole, an oral antifungal, in humans.

Authors:  C Brass; J N Galgiani; T F Blaschke; R Defelice; R A O'Reilly; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome.

Authors:  A Tavitian; J P Raufman; L E Rosenthal; J Weber; C A Webber; H P Dincsoy
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

7.  Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

Authors:  G Lake-Bakaar; W Tom; D Lake-Bakaar; N Gupta; S Beidas; M Elsakr; E Straus
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

Review 8.  Clinical pharmacokinetics of ketoconazole.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

9.  Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.

Authors:  D A Goff; S L Koletar; W J Buesching; J Barnishan; R J Fass
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

10.  Effect of pH on disintegration and dissolution of ketoconazole tablets.

Authors:  J A Carlson; H J Mann; D M Canafax
Journal:  Am J Hosp Pharm       Date:  1983-08
View more
  27 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Pharmacokinetic drug interaction profiles of proton pump inhibitors.

Authors:  Henning Blume; Frank Donath; André Warnke; Barbara S Schug
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.

Authors:  Marija Tubic-Grozdanis; Michael B Bolger; Peter Langguth
Journal:  AAPS J       Date:  2008-04-02       Impact factor: 4.009

4.  Inhibition of antifungal therapy by gastric acid suppressants.

Authors:  Harry W Daniell
Journal:  Intensive Care Med       Date:  2015-02-21       Impact factor: 17.440

5.  Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling.

Authors:  Andy Z X Zhu; Ming-Chih David Ho; Christopher K Gemski; Bei-Ching Chuang; Mingxiang Liao; Cindy Q Xia
Journal:  AAPS J       Date:  2016-09-06       Impact factor: 4.009

6.  Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial.

Authors:  Dalga D Surofchy; Lynda A Frassetto; Leslie Z Benet
Journal:  Pharm Res       Date:  2019-09-04       Impact factor: 4.200

Review 7.  Meal-Time Supplementation with Betaine HCl for Functional Hypochlorhydria: What is the Evidence?

Authors:  Thomas G Guilliams; Lindsey E Drake
Journal:  Integr Med (Encinitas)       Date:  2020-02

8.  The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria.

Authors:  Marc R Yago; Adam Frymoyer; Leslie Z Benet; Gillian S Smelick; Lynda A Frassetto; Xiao Ding; Brian Dean; Laurent Salphati; Nageshwar Budha; Jin Y Jin; Mark J Dresser; Joseph A Ware
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

Review 9.  Individualized therapy for gastroesophageal reflux disease: potential impact of pharmacogenetic testing based on CYP2C19.

Authors:  Takahisa Furuta; Mitsushige Sugimoto; Naohito Shirai
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

10.  Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.

Authors:  Gopal Krishna; Allen Moton; Lei Ma; Matthew M Medlock; James McLeod
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.